I have been buying the oct2.5 for the whole range following it down from 5.3. I think my last buy was .70
Say after two earnings reports it goes to 15. That's 12.50 intrinsic for 0.70
Same boat as you almost with my losses. I placed a large bet on HERO offshore before they reported unexpected high earnings and outlook. The short machine took them down out of the money and I expired worthless.
Who would ever guess that the short machine would go after increasing profits, decreasing debt and cashflow tripling. they can do what ever they want to who ever they want in spite of fundamentals. In tandem with their media machine bashing away.
I dunno. the opportunities they supply are outstanding if you happen to have a keg of dry powder at the time. Look at GALE. that is an easy triple or even ten bagger at current price.
I'm stickin with The Zog though.
You are all about leverage.
Leverage tamed my wild side. Even at that, my april 2.5's nearly expired worthless after losing 2.60 of intrinsic value back to Feb. I was hoping an earnings leak would spike us back above 5.
FYI from Nation Public Radio. I only copied one third of it, you can use the engine to find the rest.
MoxDuo for the first time combines morphine and oxycodone in one capsule. It's designed to provide quick relief to patients suffering severe pain from accidents or surgeries, such as knee replacements, back surgeries or cancer operations, says Ed Rudnic, COO of , the company that makes Moxduo.
The drug allows patients to take lower doses of the two narcotics than they'd need if they took either of the medicines alone, Rudnic says.
"We believe that we've achieved some benefit in reducing the risk of some of the respiratory complications of these strong opioids," he says.
Suppressed breathing and other respiratory complications are the most serious risks of these drugs — the main reason people die from taking too much.
Some pain experts think the idea behind Moxduo is a good one. A lot of patients can't take enough morphine or oxycodone to ease their discomfort because of the risk to breathing and other side effects, such as nausea, vomiting, dizziness and severe itchiness.
Patients who could theoretically benefit from such a pill are "normal people like you and me," says of Harvard Medical School. "And then suddenly we get in a terrible accident or have surgery and ... we need something. And the typical agents are used, and suddenly all these terrible side effects come up."
But Audette is not convinced the company has yet proved that Moxduo has fewer side effects.
"They haven't really done the hard work of absolutely showing ... in humans with real pain problems that synergy is making a big difference," Audette says, "compared to just using the agents that we [already] have available."
And some experts worry that Moxduo will come with its own problems.
Have you taken a look at GALE lately? They destroyed it on a broad takedown from seven to below two even with growing Abstral sales.
The theft machine can do what ever they want to whomever they want, it seems.
No wonder the hypocrisy team went all out to bash The Zog and her little market taker.
I am starting to believe our resident painmd that this could go above fifty in time.
Every state has a board of pharmacists also if needed.
Hmmm... I wonder if all the States attorneys put zoh up front and center in a hapless way. If I were on the state board of pharm I would take note if my AG wanted to ban a much needed formulation.
A lot of new long holders in the last month will make it painful for covering.
18 by January wonth.
Look to the right at the five day chart. Mini cup with handle.
Is this a fractal?
But that's not all, Lookee here. If you order before midnight you don't get one, No you get two. an extra tree branch to keep in your vehicle or give to a friend. All you have to do is pay shipping and handling on the free unit.
Offer void where trees are banned. hah or contraband.
amen to that.
As if Zoh noZoh will make any statistical difference in the big picture. Reminds of the self-righteous prohibitionists who thought it was ok to poison alcohol users ninety years ago.
There are deep pocket entities who will make trouble for Z where and when they have a chance.
If Purdue and others each grosses one billion per year on opiate distribution, it is easy to justify a few million in well placed media oulets to keep up the skeer. [and pay a few short houses to keep the pressure on Z's stock price] In the long run, it will not succeed in keeping the markets away from Z, but it will give serious pause to anyone who is uppity enough to challenge Big Pharm with a needed and superior product.
We need a few rulings that award Z some legal expense compensation.
He never sold because he never owned, and if he sold, I got some of his shares at 2.48
Paid soft basher masquerading as a thoughtful "investor".
and if regular er remains available when the abuse resistant species arrives, who in their right mind would, on an established regimen, switch over to an abuse deterrent that does not even apply to their situation.?
So now he's an ear doctor.
doctors, too many of them speak with authority not earned.
Shorts in control, like with every stock these days.
I just put in five consecutive buys bidding at 2.80 and the price keeps going down even though my bid is well above the ask.
A controlled rise works in their favor, and they have the algorithmic technology to short and cover all the way up.
The thing that would kill them now is an advance sales report to jump this thing into an irreversible gap up before earnings.